EcoDrugPlus

Steroid-5-Alpha-Reductase, Alpha Polypeptide 2a

Ensembl ID : ENSPFOG00000018194
Gene Symbol: SRD5A2A
1 Cross references
208 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSPFOG00000006972
Gene Symbol: SOAT1
3 Cross references
210 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSPFOG00000004625
Gene Symbol: TACR1
4 Cross references
194 Possible Orthologues:

Tachykinin Receptor 1b

Ensembl ID : ENSPFOG00000018524
Gene Symbol: TACR1B
1 Cross references
193 Possible Orthologues:

Tachykinin Receptor 2

Ensembl ID : ENSPFOG00000015602
Gene Symbol: TACR2
1 Cross references
196 Possible Orthologues:

Tachykinin Receptor 3

Ensembl ID : ENSPFOG00000001731
Gene Symbol: TACR3
3 Cross references
216 Possible Orthologues:

Telomerase Reverse Transcriptase

Ensembl ID : ENSPFOG00000014918
Gene Symbol: TERT
3 Cross references
189 Possible Orthologues:

Thromboxane A Synthase 1

Ensembl ID : ENSPFOG00000007921
Gene Symbol: TBXAS1
3 Cross references
219 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSPFOG00000023003
Gene Symbol: TBXA2R
3 Cross references
192 Possible Orthologues:

Thymidine Phosphorylase

Ensembl ID : ENSPFOG00000012283
Gene Symbol: TYMP
4 Cross references
172 Possible Orthologues:

Thymidylate Synthetase

Ensembl ID : ENSPFOG00000024833
Gene Symbol: TYMS
3 Cross references
224 Possible Orthologues:

Thyroid Hormone Receptor Beta

Ensembl ID : ENSPFOG00000006046
Gene Symbol: THRB
3 Cross references
389 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).